Picture of Mersana Therapeutics logo

MRSN Mersana Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Mersana Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments99.8255178281209
Net Total Accounts Receivable
Net Total Receivables0300
Prepaid Expenses
Total Current Assets101259189319214
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment4.7612.714.914.511.5
Other Long Term Assets
Total Assets108273206334226
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities24.13047.591.563.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities29.245.384.4242189
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity78.322812292.136.9
Total Liabilities & Shareholders' Equity108273206334226
Total Common Shares Outstanding